WCLC 2023
Novel science and breakthroughs presented at the 2023 World Conference on Lung Cancer, which took place September 9-12, 2023, in Singapore.
A study of patients with NSCLC and cachexia sought to assess how first-line therapy affects quality of life.
A study examined patterns of post-treatment surveillance for NSCLC.
A study assessed the impact of the COVID-19 pandemic on lung cancer in Brazil.
A study sought to ascertain the role of occupation in the risk of SCLC and adenocarcinoma in Spanish women.
Smoking is a well-known driver of lung cancer risk, and liquid biopsies have known promise in reducing lung cancer mortality.
The results of a study that aimed to subclassify SCLC based on certain immunoexpressions.
A study assessed the impact of immunotherapy on OS in patients with malignant pleural mesothelioma.
A study showed that monotherapy with datopotamab deruxtecan is safe and effective in pretreated patients with NSCLC.
Adoptive cell therapy with autologous TILs was studied to determine its viability as a treatment option for mesothelioma.
A cohort study sought to compare the surgeons’ workload impact between 30 VATS and 30 RATS cases.
Advertisement
Advertisement
